The mouse light-dark paradigm: A review

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 1, 2001, Pages 141-166

  Hascoët, Martine ^a   Bourin, Michel ^a   Nic Dhonnchadha, Brid A ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Animal models; Antidepressants; Anxiolytics; Light dark test; Mice

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 (4 CHLOROPHENYL) 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 8 [2 [(2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL)METHYLAMINO]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE MESYLATE; ALPRAZOLAM; ANPIRTOLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BEMESETRON; BENZODIAZEPINE DERIVATIVE; BRETAZENIL; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; FLESINOXAN; FLUMAZENIL; FLURAZEPAM; GEPIRONE; IPSAPIRONE; ITASETRON; LORAZEPAM; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; NEUROLEPTIC AGENT; ONDANSETRON; PINDOLOL; PSYCHOSTIMULANT AGENT; RITANSERIN; SEROTONIN AGONIST; UNINDEXED DRUG; ZACOPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; APPARATUS, EQUIPMENT AND SUPPLIES; AVERSION; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HABITUATION; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; REVIEW; SCORING SYSTEM;

EID: 0035101473     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00151-2     Document Type: Article

References (79)

1. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model
2. The interaction of R(+) and S(-) zacopride with PCPA to modify rodent aversive behaviour
3. Ketotifen and its analogues reduce aversive responding in the rodent
4. 5-HT receptors as targets for the development of novel anxiolytic drugs/ models, mechanisms and future directions
5. A simple habituation test in the mouse
6. Comparison of different behavioural test situations used in Psychopharmacology for measurement of anxiety
7. Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice
8. Anxiogenic effects of methyl-β-carboline-carboxylate in a light/dark choice situation
9. PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice
10. Actions of 5HT1A ligands and standard anxiolytics on mouse exploratory behaviour in a two compartment light: Dark arena
11. Behavioural studies of WAY 100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety
12. Further characterisation of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines
13. A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety
14. The effects of DAU 6215, a novel 5HT3 antagonist in animal models of anxiety
15. Animal models of anxiety: Are they suitable for predicting drug action in humans?
16. A schematic representation of the psychopharmacological profile of antidepressants
17. Effects of the 5-HT receptors antagonist GR38032F, ICS 205-930 and BRL 43694 in tests for anxiolytic activity
18. Anxiolytic effects of CCK-B antagonists
19. The effect of the 5-HT3 receptor antagonist, RS 42358-197, in animal models of anxiety
20. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse
21. Exploration of mice in a black and white box: Validation as a model of anxiety
22. Actions of buspirone in a putative model of anxiety in the mouse
23. Neuropharmacologic specificity of a simple model for the behavioural actions of benzodiazepines
24. Exploratory behaviour models of anxiety in mice
25. Behavioural phenotypes of inbred mouse strains: Implication and recommendations for molecular studies
26. Base line exploratory activity predicts anxiolytics responsiveness to diazepam in five mouse strains
27. Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines
28. Absence of intrinsic antagonist actions of benzodiazepine antagonist on an exploratory model of anxiety in the mouse
29. The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate
30. The anxiolytic like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test
31. Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorate and ipsapirone
32. Can animal test of anxiety detect anti-panic compounds?
33. 3 receptor antagonist, BRL 46470A, on the behavior of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage
34. Effect of acute and subchronic administration of ritanserin on the social behaviour of mice
35. Effects of repeated treatment with antidepressant drugs on the 24 hour behaviour in the light-dark synchronised mice
36. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More then 30 years of research
37. Variability in the effects of-5HT related compounds in experimental models of anxiety: Evidence for multiple mechanisms of 5-HT in anxiety or never ending story?
38. 2A receptor antagonist S21357
39. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents
40. m-chlorophenylpiperazine enhances neophobic and anxious behaviour in mice
41. CCK receptor antagonists in animal models of anxiety: Comparison between exploration tests, conflict procedures and a model based on defensive behaviours
42. Risk assessment behaviour evaluation of utility inn the study of 5-HT related drugs in the rat elevated plus maze
43. 5-Hydroxytryptamine pathways in anxiety and its treatment
44. Serotonin mechanisms in animal models of anxiety
45. Multiple serotonin mechanisms in animal models of anxiety: Environmental, emotional and cognitive factors
46. A new approach to the light/dark procedure in mice. Pharmacol
47. The influence of buspirone and its metabolite1-PP on the activity of paroxetine in the mouse light dark paradigm and four plates test
48. Influence of age on behavioural response in the light-dark paradigm
49. Anxiolytic like effects of antidepressants after acute administration in a four plate test in mice
50. A review of the validity and variability of the elevated plus maze as an animal model of anxiety
51. Effects of xanthine derivatives in a light/dark test in mice and contribution of adenosine receptors
52. 3-receptor antagonist, in a light/dark test measuring anxiety in mice
53. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice
54. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice
55. 3 receptors
56. A decreased frequency of peeking out from the dark compartment - The only constant index of the effect of anxiogens on the behaviour of mice in light-darkness chamber
57. Anxiolytic-like effect of paroxetine in a rat social interaction test
58. Ethologically-based models of anxiety disorders
59. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics
60. The mechanism of anxiogenic-like effect of antidepressants on exploratory behaviour in rats
61. Anxiolytic like action of anpirtoline in a mouse light dark aversion paradigm
62. Anxiolytic and sedative effects of 5-HT1A ligands, 8-OHDPAT and MDL 73005EF, in mice
63. 5-HT3 receptor antagonists and anxiety; a preclinical and clinical review
64. Neuropharmacological and physiological validation of a computer-controlled two compartment black and white box for the assessment of anxiety
65. Validation of open/closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
66. Relationship between memory and fear: Developmental and pharmacological studies
67. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus maze and light/dark test of anxiety in mice
68. 1A receptors play an important role in modulation of behaviour of rats in a two-compartment black and white box
69. Behavioural profiles of SSRIs in animals models of depression, anxiety and aggression: Are they all alike?
70. Flesinoxan: Anxiolytic activity in animal models
71. The modified light/dark transition test in mice: Evaluation of classic and putative anxiolytic and anxiogenic drugs
72. Anxiolytic action of CGS 9896 on mouse exploratory behaviour
73. The anxiolytic activities of 5-HT3 antagonists in laboratory animals
74. Cholecystokinin in anxiety
75. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-o1-20-one
76. The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist
77. Comparative effects of zacopride, GR 38032F, buspirone and diazepam in the mouse light/dark exploratory model
78. A fully automated light/dark apparatus useful for comparing anxiolytic agents
79. Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test